A carregar...

ISS-Ⅲ期伴1q扩增或17p缺失双重打击初诊多发性骨髓瘤患者的预后分析

OBJECTIVE: To evaluate the prognostic significance of combining ISS-Ⅲ and high risk cytogenetic abnormalities [HRCAs, including 1q gain/amplification and del (17p) ] in patients with newly-diagnosed multiple myeloma (NDMM) . METHODS: The clinical characteristics and relevant variables were retrospec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Zhonghua Xue Ye Xue Za Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: Editorial office of Chinese Journal of Hematology 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342365/
https://ncbi.nlm.nih.gov/pubmed/31856439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.11.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!